Nitrosamine Impurities in Pharma

Formulation Development Services for Pharma, Biotech & Generics

Published Nov 12, 2025 by pharmaffiliates
Formulation Development Services for Pharma, Biotech & Generics

Pharmaceutical formulation development plays a decisive role in turning an API into a safe, stable, and effective drug product. With increasing regulatory expectations and complex molecules entering development, pharma companies rely on specialized CROs/CRDMOs for robust, scalable, and compliant formulation solutions.

Our formulation development services support early R&D to clinical batches, ensuring your product meets quality, stability, and regulatory requirements.

Overview of Our Formulation Development Services

Developing a formulation is far more than mixing an API with excipients. It involves understanding how the molecule behaves, anticipating its stability and performance challenges, and engineering a dosage form that maintains safety and efficacy throughout its lifecycle. Whether supporting a new chemical entity or a generic product, our formulation development approach is systematic, data-driven, and aligned with global regulatory expectations.

Our workflow covers:

  • Pre-formulation studies
  • Formulation design and optimization
  • Analytical method development
  • Stability and compatibility assessment
  • Scale-up and technology transfer
  • Documentation for regulatory submissions

Pre-Formulation Studies (ICH Q6A)

Pre-formulation lays the scientific foundation for dosage-form design. By characterizing an API early, we help predict development risks and determine the most suitable formulation strategy.

Key Parameters Assessed

  • Solubility Profiling: Establishes dissolution behavior and guides solubility-enhancement strategies.
  • Polymorphism: Determines solid-state forms and their influence on stability and bioavailability.
  • Hygroscopicity: Identifies moisture sensitivity and implications for packaging/storage.
  • pKa, LogP/LogD: Supports understanding of ionization, permeability, and formulation route.
  • Thermal Behavior (DSC/TGA): Detects melting transitions and potential interactions.
  • Excipient Compatibility: Identifies excipients that maintain API integrity.
  • Stress Stability (ICH Q1A): Helps map degradation pathways.

These insights help prevent downstream formulation failures and streamline optimization.

Formulation Optimization (ICH Q8)

After understanding the API, we refine formulation attributes using a structured scientific approach. Our team employs Design of Experiments (DoE) and systematic screening to identify excipient combinations, release profiles, and stability-enhancing strategies.

Dosage Forms We Develop

  • Tablets & Capsules: IR, SR, MR, DR formulations with optimized dissolution performance.
  • Oral Suspensions: Stable and uniform suspensions for improved patient compliance.
  • Injectable Solutions: Sterile aqueous and non-aqueous formulations.
  • Lyophilized Products: Freeze-dried options for improved shelf life.
  • Transdermal Patches: Controlled-release systems enabling sustained drug delivery.
  • Topical Gels & Creams: Designed for targeted or systemic delivery.
  • Inhalation Formulations: DPI, solution, and suspension-based delivery.
  • Suppositories & Ointments: Tailored for rectal or vaginal administration.
  • Nutraceutical Formulations: Customized for specialized health applications.

This stage ensures the formulation is robust, manufacturable, and suitable for scale-up.

Regulatory-Compliant Development

Every formulation we develop is aligned with global expectations:

  • FDA 21 CFR
  • EMA guidelines
  • ICH Q6A, Q8, Q9, Q10 standards
  • USP and EP monographs

This alignment reduces regulatory queries and supports smooth dossier submissions.

API Development & Custom Synthesis Support

As a CRDMO, our capabilities extend beyond formulation. Our API development and custom synthesis teams support small and large molecules, including:

  • Chiral compounds
  • Stable isotope-labeled compounds
  • Key intermediates
  • Impurities and metabolites
  • Reference standards

This integrated approach ensures seamless communication between API and formulation teams, accelerating project timelines.

Impurity Profiling (ICH Q3A/Q3B)

We provide comprehensive impurity characterization for both API and formulations using:

  • HPLC/UPLC
  • GC/GC-MS
  • ICP-MS
  • LC-MS/MS
  • FTIR
  • NMR

These datasets support safety evaluations, stability studies, and regulatory filings.

Analytical Services for Product Development

Analytical R&D is central to formulation success. We offer:

  • Assay & related substances analysis
  • Dissolution method development
  • Stability-indicating method development
  • Solid-state characterization
  • Thermal analysis

All methods are validated as per ICH Q2.

Stability Studies (ICH Q1A)

We conduct:

  • Accelerated stability studies
  • Long-term stability studies
  • Photostability assessments
  • Forced degradation studies
  • Packaging compatibility evaluations

These studies determine product shelf life and degradation pathways.

Regulatory Support

We assist partners with:

Why Pharmaffiliates

  • Proven expertise across complex APIs and specialty formulations
  • Advanced analytical infrastructure (HPLC, NMR, ICP-MS, LC-MS, GC)
  • Integration of API, impurity, and formulation development
  • Compliance with FDA, EMA, and ICH frameworks
  • Strong global presence and technical communication

Conclusion

Pharmaffiliates deliver scientifically strong, regulatory-ready formulation and API development solutions. With a focus on precision, analytical excellence, and global compliance, we help organizations move molecules from concept to commercialization efficiently and confidently.

FAQs

  1. What formulation services do you offer? We provide pre-formulation, formulation optimization, analytical development, stability studies, and regulatory support.
  2. Which dosage forms do you specialize in? Tablets, capsules, suspensions, injectables, lyophilized products, topicals, inhalation systems, and more.
  3. Do you follow global regulatory standards? Yes, we follow ICH, FDA, EMA, USP, and EP guidelines.
  4. What analytical techniques do you use? HPLC, GC, NMR, FTIR, LC-MS/MS, ICP-MS, DSC, TGA, and more.
  5. Can you support regulatory submissions? Yes, including CTD dossiers, ANDA/DMF support, and query responses.

Leave a Reply

pharmaffiliates